|
Market Closed -
Australian S.E.
01:11:42 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.0400 AUD | +2.56% |
|
+5.26% | -56.99% |
| 05-18 | Invion signs first ophthalmology collaboration agreement with Sangmyung Innovation | RE |
| 02-26 | Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2025 | CI |
| Market Cap | 3.82M 2.71M 2.34M 2.2M 2M 3.76M 259M 25.77M 10.07M 130M 10.17M 9.95M 431M | P/E 2024 |
-4.44x | P/E 2025 | -0.9x |
|---|---|---|---|---|---|
| Enterprise Value | 2.97M 2.11M 1.82M 1.71M 1.55M 2.92M 201M 20.03M 7.83M 101M 7.91M 7.74M 335M | EV / Sales 2024 |
6.94x | EV / Sales 2025 | - |
| Free-Float |
68% | Yield 2024 * |
-
| Yield 2025 | - |
| 24-09-18 | Invion Limited (ASX:IVX) Prostate Cancer Trial Results | AQ |
| 22-07-20 | Invion : Activities Report and Appendix 4C | PU |
| 22-06-19 | Invion : Notification regarding unquoted securities - IVX | PU |
| 22-04-20 | Invion : Activities Report and Appendix 4C | PU |
| 22-03-20 | Invion : Notification regarding unquoted securities - IVX | PU |
| 1 day | +2.56% | ||
| 1 week | +5.26% | ||
| 1 month | +17.65% | ||
| 3 months | -29.82% | ||
| 6 months | -50.62% | ||
| Current year | -56.99% |
| 1 week | 0.04 |  | 0.04 |
| 1 month | 0.04 | | 0.05 |
| Current year | 0.03 | | 0.1 |
| 1 year | 0.03 | | 0.2 |
| 3 years | 0.03 | | 0.8 |
| 5 years | 0.03 | | 3.4 |
| 10 years | 0.03 | | 5.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thian Chew
CEO | Chief Executive Officer | - | 2020-10-31 |
Melanie Leydin
DFI | Director of Finance/CFO | 53 | 2020-07-12 |
Brendon Lau
IRC | Investor Relations Contact | 54 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Thian Chew
CHM | Chairman | - | 2017-11-30 |
Alan Yamashita
BRD | Director/Board Member | 76 | 2019-02-11 |
Melanie Leydin
BRD | Director/Board Member | 53 | 2024-08-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.56% | +5.26% | -56.04% | -92.73% | 3.1M | |
| -1.78% | -1.68% | +1.48% | +15.31% | 48.42B | |
| +0.85% | -0.70% | +460.88% | +563.55% | 43.66B | |
| -2.40% | -0.23% | +8.13% | +71.41% | 39.51B | |
| -2.01% | -0.85% | +23.85% | +8.73% | 38.95B | |
| -0.50% | +0.85% | +20.60% | +49.65% | 32.61B | |
| +0.38% | -3.23% | - | - | 16.32B | |
| -0.59% | -2.06% | +26.35% | +118.09% | 16.15B | |
| +0.49% | +0.92% | +4.11% | +23.67% | 14.16B | |
| -0.43% | +4.70% | +78.74% | +33.31% | 13.37B | |
| Average | -0.34% | +0.19% | +63.12% | +87.89% | 26.31B | |
| Weighted average by Cap. | -0.91% | +0.59% | +95.83% | +132.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.69M 2.62M 2.26M 2.13M 1.93M 3.63M 250M 24.91M 9.74M 125M 9.83M 9.62M 417M | - |
| Net income | -5.63M -3.99M -3.45M -3.24M -2.94M -5.54M -381M -37.94M -14.83M -191M -14.98M -14.65M -635M | -8.81M -6.24M -5.39M -5.07M -4.61M -8.66M -597M -59.38M -23.22M -299M -23.44M -22.93M -994M |
| Net Debt | -784K -555K -480K -451K -410K -771K -53.11M -5.28M -2.07M -26.6M -2.09M -2.04M -88.39M | -850K -603K -521K -489K -445K -837K -57.65M -5.73M -2.24M -28.87M -2.26M -2.21M -95.93M |
Employees
4
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | A$0.0400 | +2.56% | 20,842 |
| 26-08-13 | A$0.0390 | +2.63% | 215,144 |
| 26-08-11 | A$0.0380 | -2.56% | 111,435 |
| 26-08-10 | A$0.0390 | +2.63% | 529 |
- Stock Market
- Stocks
- IVX Stock
Select your edition
All financial news and data tailored to specific country editions
